Skip to main content
. 2014 Nov;10(4):309–314. doi: 10.2174/1573403X10666140513103709

Fig. (1).

Fig. (1)

Choice of pharmacological agent for cardioversion in an acute setting. Choice of an antiarrhythmic drug is dependent on availability and underlying structural heart disease. Optimum drug choices are indicated in bold. CHF = congestive heart failure.